Evolution of protein-bound uraemic solutes during predilution haemofiltration

Journal of Nephrology

Volumn 22, Issue 3, 2009, Pages 352-357

  Meert, Natalie ^a   Beerenhout, Charles ^b   Schepers, Eva ^a   Glorieux, Griet ^a   Kooman, Jeroen ^c   Vanholder, Raymond ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b MÁXIMA MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Convection; Dialysis; Haemofiltration; Predilution; Protein bound; Uraemic toxins

Indexed keywords

HIPPURIC ACID; INDICAN; INDOLEACETIC ACID; PARA CRESOL; PROPIONIC ACID; UNCLASSIFIED DRUG; UREMIC TOXIN; UROFURAN ACID; 3 (3 CARBOXY 4 METHYL 5 PROPYL 2 FURYL)PROPIONIC ACID; 3-CARBOXY-4-METHYL-5-PROPYL-2-FURANPROPANOIC ACID; 4-CRESOL; CRESOL; FURAN DERIVATIVE; HIPPURIC ACID DERIVATIVE; INDOLEACETIC ACID DERIVATIVE; PROPIONIC ACID DERIVATIVE;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HEMODILUTION; HEMOFILTRATION; HUMAN; INTERMETHOD COMPARISON; MALE; PROTEIN BINDING; SOLUBILITY; SOLUTE; AGED; METABOLISM; MIDDLE AGED; RENAL REPLACEMENT THERAPY; UREMIA;

ADULT; AGED; CRESOLS; FEMALE; FURANS; HEMOFILTRATION; HIPPURATES; HUMANS; INDOLEACETIC ACIDS; MALE; MIDDLE AGED; PROPIONIC ACIDS; PROTEIN BINDING; RENAL DIALYSIS; UREMIA;

EID: 69449085276     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Lesaffer G, De Smet R, Lameire N, Dhondt A, Duym P, Vanholder R. Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane. Nephrol Dial Transplant. 2000;15:50-57.
2. Vanholder R, De Smet R, Lameire N. Protein-bound uremic solutes: the forgotten toxins. Kidney Int Suppl. 2001;78:S266-S270.
3. Ledebo I. Principles and practice of hemofiltration and hemodiafiltration. Artif Organs. 1998;22:20-25.
4. McCarthy JT, Moran J, Posen G, et al. A time for rediscovery: chronic hemofiltration for end-stage renal disease. Semin Dial. 2003;16:199-207.
5. Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y. Removal of the protein-bound solute p-cresol by convective transport: a randomized crossover study. Am J Kidney Dis. 2004;44:278-285.
6. Beerenhout CH, Luik AJ, Jeuken-Mertens SG, et al. Predilution on-line haemofiltration vs low-flux haemodialysis: a randomized prospective study. Nephrol Dial Transplant. 2005;20:1155-1163.
7. Dhondt AW, Vanholder RC, De Smet RV, et al. Studies on dialysate mixing in the Genius single-pass batch system for hemodialysis therapy. Kidney Int. 2003;63:1540-1547.
8. Fagugli RM, De Smet R, Buoncristiani U, Lameire N, Vanholder R. Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis. Am J Kidney Dis. 2002;40:339-347.
9. Canaud B, Bragg-Gresham JL, Marshall MR, et al. Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int. 2006;69:2087-2093.
10. Ronco C, Orlandini G, Brendolan A, Lupi A, La Greca G. Enhancement of convective transport by internal filtration in a modified experimental hemodialyzer: technical note. Kidney Int. 1998;54:979-985.
11. Locatelli F, Di Filippo S, Manzoni C. Removal of small and middle molecules by convective techniques. Nephrol Dial Transplant. 2000;15(Suppl 2):37-44.
12. Niwa T, Yazawa T, Kodama T, Uehara Y, Maeda K, Yamada K. Efficient removal of albumin-bound furancarboxylic acid, an inhibitor of erythropoiesis, by continuous ambulatory peritoneal dialysis. Nephron. 1990;56:241-245.
13. Niwa T, Asada H, Tsutsui S, Miyazaki T. Efficient removal of albumin-bound furancarboxylic acid by protein-leaking hemodialysis. Am J Nephrol. 1995;15:463-467.
14. Meyer TW, Leeper EC, Bartlett DW, et al. Increasing dialysate flow and dialyzer mass transfer area coefficient to increase the clearance of protein-bound solutes. J Am Soc Nephrol. 2004;15:1927-1935.
15. Costigan MG, Callaghan CA, Lindup WE. Hypothesis: is accumulation of a furan dicarboxylic acid (3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid) related to the neurological abnormalities in patients with renal failure? Nephron. 1996;73:169-173.
16. Deguchi T, Isozaki K, Yousuke K, Terasaki T, Otagiri M. Involvement of organic anion transporters in the efflux of uremic toxins across the blood-brain barrier. J Neurochem. 2006;96:1051-1059.
17. Dou L, Cerini C, Brunet P, et al. p-Cresol, a uremic toxin, decreases endothelial cell response to inflammatory cytokines. Kidney Int. 2002;62:1999-2009.
18. Vanholder R, De Smet R, Waterloos MA, et al. Mechanisms of uremic inhibition of phagocyte reactive species production: characterization of the role of p-cresol. Kidney Int. 1995;47:510-517.
19. Wratten ML, Tetta C, De Smet R, et al. Uremic ultrafiltrate inhibits platelet-activating factor synthesis. Blood Purif. 1999;17:134-141.
20. De Loor H, Bammens B, Evenepoel P, De Preter V, Verbeke K. Gas chromatographic-mass spectrometric analysis for measurement of p-cresol and its conjugated metabolites in uremic and normal serum. Clin Chem. 2005;51:1535-1538.
21. Martinez AW, Recht NS, Hostetter TH, Meyer TW. Removal of p-cresol sulfate by hemodialysis. J Am Soc Nephrol. 2005;16:3430-3436.
22. Schepers E, Meert N, Glorieux G, Goeman J, Van der Eycken J, Vanholder R. p-Cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production. Nephrol Dial Transplant. 2007;22:592-596.
23. Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y. Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms. Kidney Int. 2003;64:2238-2243.
24. Bammens B, Evenepoel P, Keuleers H, Verbeke K, Vanrenterghem Y. Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int. 2006;69:1081-1087.
25. De Smet R, Van Kaer J, Van Vlem B, et al. Toxicity of free p-cresol: a prospective and cross-sectional analysis. Clin Chem. 2003;49:470-478.